While our findings suggest that altered activity of the IL-6/IL-6R pathway could be a risk factor for depression, disentangling the issue of IL-6 classic vs trans-signalling is beyond the scope of population genomics approaches as full effects of genetic variants used are unknown. This evidence concerns the gene IL6 and major depressive disorder.